our studies yielded the following results : in chronic stationary psoriasis , systemic treatment with csa in very low doses ( 2.5 mg/kg/d , 13 patients , 10 weeks ) led to a 75 % reduction of the pasi score without any side reactions .
C0033860
psoriasis
C0010592
csa